EcoDrugPlus

Udp-Glucose Ceramide Glucosyltransferase

Ensembl ID : ENSUPAG00010009566
Gene Symbol: UGCG
1 Cross references
211 Possible Orthologues:

Wee1 G2 Checkpoint Kinase

Ensembl ID : ENSUPAG00010023319
Gene Symbol: WEE1
1 Cross references
226 Possible Orthologues:

Acetylcholinesterase (Cartwright Blood Group)

Ensembl ID : ENSUPAG00010017479
Gene Symbol: ACHE
3 Cross references
233 Possible Orthologues:

Activin A Receptor Like Type 1

Ensembl ID : ENSUPAG00010002166
Gene Symbol: ACVRL1
1 Cross references
353 Possible Orthologues:

Activin A Receptor Type 2b

Ensembl ID : ENSUPAG00010010442
Gene Symbol: ACVR2B
3 Cross references
257 Possible Orthologues:

Adenosine A1 Receptor

Ensembl ID : ENSUPAG00010008063
Gene Symbol: ADORA1
1 Cross references
269 Possible Orthologues:

Adenosine A2a Receptor

Ensembl ID : ENSUPAG00010004649
Gene Symbol: ADORA2A
3 Cross references
260 Possible Orthologues:

Adenosine A2b Receptor

Ensembl ID : ENSUPAG00010021956
Gene Symbol: ADORA2B
1 Cross references
200 Possible Orthologues:

Adenosine A3 Receptor

Ensembl ID : ENSUPAG00010022072
Gene Symbol: ADORA3
1 Cross references
89 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSUPAG00010005801
Gene Symbol: ADRA1B
1 Cross references
263 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSUPAG00010001689
Gene Symbol: ADRA1D
1 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSUPAG00010023216
Gene Symbol: ADRA2A
1 Cross references
230 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).